Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Peter Volkers"'
Publikováno v:
Statistics in medicine [Stat Med] 2007 Jan 15; Vol. 26 (1), pp. 230-3; author reply 234-5.
Autor:
Johannes Dodt, Andreas Reuter, Johannes Oldenburg, Christoph Krettler, Peter Volkers, Mohammad Suhail Akhter, Arijit Biswas, Christoph Reinhart, Sneha Singh
Publikováno v:
Hamburger Hämophilie Symposion Hamburg, Germany.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f2d711c1b18ee3487b3c63868ac805f
https://doi.org/10.1055/s-0040-1721610
https://doi.org/10.1055/s-0040-1721610
Autor:
Arijit Biswas, Peter Volkers, Johannes Dodt, Helen Philippou, V. Ivaškevičius, Diana Imhof, Emma Hethershaw, S. Singh, J. Oldenburg
Publikováno v:
Science meets clinical practice.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d66ef9b751165d12b5ac92a011bf4ece
https://doi.org/10.1055/s-0039-1680157
https://doi.org/10.1055/s-0039-1680157
Autor:
Johannes Dodt, Arijit Biswas, Diana Imhof, Emma Hethershaw, Peter Volkers, S. Singh, Vytautus Ivaskevicius, Johannes Oldenburg, Helen Philippou
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-18 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-18 (2019)
The dimeric FXIII-A2, a pro-transglutaminase is the catalytic part of the heterotetrameric coagulation FXIII-A2B2 complex that upon activation by calcium binding/thrombin cleavage covalently cross-links preformed fibrin clots protecting them from pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b280bb0396887d374f3a5c2b310245b9
https://pubmed.ncbi.nlm.nih.gov/31383913
https://pubmed.ncbi.nlm.nih.gov/31383913
Autor:
Elena Santagostino, Jenny Goudemand, Kay Martin Hanschmann, Peter William Collins, Thierry Calvez, Daniel P. Hart, Ben Palmer, Peter Volkers, Ella M. van Hardeveld, Hervé Chambost, Charles R. M. Hay, Brigitte Keller-Stanislawski, Rolf Ljung, Virginie Demiguel, Marijke van den Berg
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 25(3)
INTRODUCTION: Standard treatment of congenital haemophilia A is based on replacement therapy with coagulation factor VIII (FVIII) products. A major complication of FVIII therapy is the occurrence of IgG alloantibodies (inhibitors) that neutralize FVI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82167c1450474efdc3eb072b054e2b5e
https://pubmed.ncbi.nlm.nih.gov/31066174
https://pubmed.ncbi.nlm.nih.gov/31066174
Autor:
Dirk Mentzer, Hans-Peter Hartung, Helmar C. Lehmann, Peter Volkers, Brigitte Keller-Stanislawski, Jürgen Prestel
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose A prospective, epidemiologic study was conducted to assess whether the 2009 pandemic influenza A(H1N1) vaccination in Germany almost exclusively using an AS03-adjuvanted vaccine (Pandemrix) impacts the risk of Guillain–Barré syndrome (GBS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8534cfdf281c59866e3573e721ab406
https://doi.org/10.1002/pds.3638
https://doi.org/10.1002/pds.3638
Autor:
Mohammad Suhail Akhter, Christoph Reinhart, Johannes Dodt, Andreas Reuter, Sneha Singh, Peter Volkers, Christoph Krettler, Arijit Biswas, Johannes Oldenburg
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 11, p 2682 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 11
International Journal of Molecular Sciences
Volume 20
Issue 11
Coagulation factor XIII (FXIII) is a plasma-circulating heterotetrameric pro-transglutaminase complex that is composed of two catalytic FXIII-A and two protective/regulatory FXIII-B subunits. FXIII acts by forming covalent cross-links within a prefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b07187cfa26522f6c60c3ef0aecbee3
https://doi.org/10.3390/ijms20112682
https://doi.org/10.3390/ijms20112682
Publikováno v:
Transfusion Medicine and Hemotherapy. 42:205-207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56b367349162b5df615d3f902c738574
https://doi.org/10.1159/000438849
https://doi.org/10.1159/000438849
Autor:
J. Hoch, C. H. Wirsing von König, W. Däubener, G. Walther-Wenke, Margarethe Heiden, B. Hornei, Peter Volkers
Publikováno v:
Vox Sanguinis. 100:359-366
Background and Objectives National guidelines for monitoring bacterial contamination of blood components were introduced in Germany in 1997. Between 1998 and 2002, numerous measures were implemented to prevent bacterial contamination. This study inve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bc2030edf85c0b24349c7ecb4909cc
https://doi.org/10.1111/j.1423-0410.2010.01432.x
https://doi.org/10.1111/j.1423-0410.2010.01432.x
Publikováno v:
British journal of haematology. 172(3)
In a factor XIIIa (FXIIIa) generation assay with recombinant FXIII-A2 (rFXIII-A2 ) free FXIII activation peptide (fAP-FXII) prolonged the time to peak (TTP) but did not affect the area under the curve (AUC) or concentration at peak (CP). Addition of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c364e5b6c86c6a92fdd99caa84197b1
https://pubmed.ncbi.nlm.nih.gov/26516704
https://pubmed.ncbi.nlm.nih.gov/26516704